DHP Korea Co. Ltd (131030.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7131030009

Price
5,760.00 KRW
Market cap
100.06 bn KRW
P/E (2025)
8.81
P/S (2025)
1.15
Dividend yield
0.00 %
Net margin
13.03 %
Return on equity (ROE)
6.88 %
Return on assets (ROA)
5.94 %

DHP Korea Co. Ltd financials

Fiscal year20242025
Revenue81.90 bn KRW87.16 bn KRW
Gross profit44.71 bn KRW48.18 bn KRW
Operating income8.59 bn KRW8.88 bn KRW
EBIT12.18 bn KRW11.12 bn KRW
Net income10.31 bn KRW11.36 bn KRW
Diluted EPS – continuing operations674.38 KRW653.79 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About DHP Korea Co. Ltd

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.